State Street
CDLX icon

State Street’s Cardlytics CDLX Stock Holding History

State Street’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$239K Hold
22,773
– – ﹤0.01% 3844
2025
Q4 		$262K Hold
22,773
– – ﹤0.01% 3832
2025
Q3 		$553K Sell
22,773
-300
-1% -$5K ﹤0.01% 3640
2025
Q2 		$380K Sell
23,073
-66,991
-74% -$1.16M ﹤0.01% 3678
2025
Q1 		$1.64M Sell
90,064
-963
-1% -$27.5K ﹤0.01% 3313
2024
Q4 		$3.38M Buy
91,027
+3,694
+4% +$141K ﹤0.01% 3121
2024
Q3 		$2.79M Sell
87,333
-1,756
-2% -$97.5K ﹤0.01% 3203
2024
Q2 		$7.31M Buy
89,089
+14,167
+19% +$1.53M ﹤0.01% 2747
2024
Q1 		$10.9M Buy
74,922
+3,036
+4% +$256K ﹤0.01% 2538
2023
Q4 		$6.62M Buy
71,886
+3,985
+6% +$405K ﹤0.01% 2811
2023
Q3 		$11.2M Buy
67,901
+1,564
+2% +$203K ﹤0.01% 2526
2023
Q2 		$4.19M Buy
66,337
+6,481
+11% +$393K ﹤0.01% 3079
2023
Q1 		$2.03M Sell
59,856
-6,661
-10% -$348K ﹤0.01% 3339
2022
Q4 		$3.84M Sell
66,517
-308
-0.5% -$19K ﹤0.01% 3155
2022
Q3 		$6.28M Buy
66,825
+580
+0.9% +$82.5K ﹤0.01% 2949
2022
Q2 		$14.8M Buy
66,245
+1,437
+2% +$481K ﹤0.01% 2456
2022
Q1 		$35.6M Buy
64,808
+2,097
+3% +$1.27M ﹤0.01% 1971
2021
Q4 		$41.4M Buy
62,711
+1,137
+2% +$869K ﹤0.01% 1941
2021
Q3 		$51.7M Buy
61,574
+1,282
+2% +$1.3M ﹤0.01% 1783
2021
Q2 		$76.5M Buy
60,292
+4,427
+8% +$5M ﹤0.01% 1522
2021
Q1 		$61.3M Buy
55,865
+4,828
+9% +$6.37M ﹤0.01% 1588
2020
Q4 		$72.9M Buy
51,037
+1,242
+2% +$1.32M ﹤0.01% 1395
2020
Q3 		$35.1M Sell
49,795
-1,684
-3% -$1.22M ﹤0.01% 1696
2020
Q2 		$36M Buy
51,479
+19,787
+62% +$11.4M ﹤0.01% 1650
2020
Q1 		$11.1M Buy
31,692
+1,599
+5% +$1.13M ﹤0.01% 2217
2019
Q4 		$18.9M Buy
30,093
+5,398
+22% +$2.64M ﹤0.01% 2172
2019
Q3 		$8.28M Buy
24,695
+1,182
+5% +$379K ﹤0.01% 2565
2019
Q2 		$6.11M Buy
23,513
+15,683
+200% +$3.14M ﹤0.01% 2727
2019
Q1 		$1.29M Buy
7,830
+394
+5% +$64.1K ﹤0.01% 3283
2018
Q4 		$805K Sell
7,436
-703
-9% -$119K ﹤0.01% 3367
2018
Q3 		$2.04M Buy
8,139
+360
+5% +$77.5K ﹤0.01% 3234
2018
Q2 		$1.69M Buy
7,779
+1,709
+28% +$316K ﹤0.01% 3319
2018
Q1 		$888K Buy
+6,070
New +$1.03M ﹤0.01% 3357

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

State Street's CDLX Position: Q1 2026 in Review

State Street held its Cardlytics (CDLX) position steady in Q1 2026 at 22,773 shares worth $239K. The position accounts for ﹤0.01% of the portfolio, ranked #3844.

State Street first reported a position in CDLX in Q1 2018 and has held it in 33 quarters since. The position peaked at $76.5M in Q2 2021. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.

  • State Street held 22,773 shares of Cardlytics worth $239K as of Q1 2026.
  • State Street left its Cardlytics share count unchanged in Q1 2026.
  • Cardlytics made up ﹤0.01% of State Street's portfolio in Q1 2026, its #3844 holding.
  • State Street first reported a position in Cardlytics in Q1 2018 and has held it in 33 quarters since.
  • State Street's Cardlytics position peaked at $76.5M in Q2 2021.
  • 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.